The frequency of S‐specific CD4+ T cells was significantly lower in both T1D and T2D participants when compared with that of ND controls (approximately 2‐ and 2.25‐fold decrease in T1D and T2D, respectively, Figure 4A). This evidence concerns the gene CD4 and type 2 diabetes mellitus.